LIFEVEST WCD 4000 SYSTEM
Report
- Report Number
- 3008642652-2013-00837
- Event Type
- Malfunction
- Date Received
- March 29, 2013
- Date of Event
- February 22, 2013
- Report Date
- March 26, 2013
- Manufacturer
- ZOLL LIFECOR CORPORATION
- Product Code
- MVK
- PMA / PMN Number
- P010030
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- NOT APPLICABLE
Narratives
DEVICE EVAL SUMMARY: DEVICE EVAL OF MONITOR SN (B)(4) HAS BEEN COMPLETED. THE REPORTED PROBLEM (WON'T POWER ON) HAS BEEN CONFIRMED. AS RECEIVED, THE MONITOR WOULD NOT FULLY POWER ON AND WAS RESETTING. DURING SERVICING, THERE WAS A SEGMENTATION FAULT WHILE PERFORMING THE FLASH MEMORY TEST. THE CAUSE OF THE INABILITY TO POWER ON IS THE FLASH MEMORY FAILURE. THE CAUSE OF THE FLASH MEMORY FAILURE HAS BEEN ISOLATED TO FLASH COMPONENTS (U102 AND U105) ON THE COMPUTER ANALOG (C/A) BOARD SN (B)(4). THE FLASH MEMORY COMPONENTS HAD INTERMITTENT BGA CONNECTIONS. THE INTERMITTENT CONNECTION IS LIKELY DUE TO A FRACTURED SOLDER CONNECTION INDUCED BY MECHANICAL STRESS. THE EXACT SOURCE OF THE MECHANICAL STRESS HAS NOT BEEN POSITIVELY IDENTIFIED BUT THE FRACTURED CONNECTION MAY HAVE BEEN ACCELERATED THROUGH ROUGH HANDLING. ROOT CAUSE ANALYSIS OF SIMILAR EVENTS FOUND THAT EXCESSIVE STRAIN ON THE PRINTED CIRCUIT ASSEMBLY (PCA) FROM SEVERE IMPACT CAN CAUSE FRACTURED SOLDER CONNECTIONS. A MECHANICAL DESIGN CHANGE (SEE PMA SUPPLEMENT S039) TO REDUCE THE PCA STRAIN WAS APPROVED BY FDA ON 12/20/2012. IMPLEMENTATION BEGAN ON 01/21/2013. RESULTS WILL BE MONITORED. NO ADVERSE EVENT RESULTED FROM THE DEFECTIVE MEMORY. THE PT WAS ISSUED A REPLACEMENT MONITOR.
A PT SERVICE REP CONTACTED ZOLL CUSTOMER SUPPORT TO REPORT THAT A (B)(6) MALE PT'S MONITOR WOULD NOT POWER ON. THE PT WAS ISSUED A REPLACEMENT MONITOR.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 129733 | LIFEVEST WCD 4000 SYSTEM | WEARABLE CARDIOVERTER DEFIBRILLATOR | MVK | ZOLL LIFECOR CORPORATION | WCD 4000 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR |